Home > Financial Ratios > CONCORD BIOTECH
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 31.8134.08--0.060.10

What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?

The latest EV/Core EBITDA ratio of CONCORD BIOTECH is 31.81 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202531.81
Mar202434.08
Mar2023-
Mar2022-0.06
Mar20210.10

How is EV/Core EBITDA of CONCORD BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 31.81
-6.66
Mar2024 34.08
0
Mar2023 0
100.00
Mar2022 -0.06
Negative
Mar2021 0.1 -

Other Financial Ratios of CONCORD BIOTECH


Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,926.0 Cr 12.2% 12.4% -28.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

12.2%

12.4%

-28.8%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses